Recent advances in the detection and management of early gastric cancer and its precursors. Issue 4 (30th July 2020)

• Record Type: Journal Article
• Authors: Waddingham, William; Nieuwenburg, Stella A V; Carlson, Sean; Rodriguez-Justo, Manuel; Spaander, Manon; Kuipers, Ernst J; Jansen, Marnix; Graham, David G; Banks, Matthew
• Is Part Of: Frontline gastroenterology. Volume 12:Issue 4(2021)
• Page Start: 322
• Page End: 331
• Publication Date: 2020-07-30
• Subjects: gastric adenocarcinoma -- gastrointesinal endoscopy -- gastric inflammation -- gastric metaplasia -- Helicobacter pylori - gastritis; Gastroenterology -- Periodicals; 616.33005
• DOI: 10.1136/flgastro-2018-101089
• Languages: English
• ISSNs: 2041-4137

Abstract

Abstract : Despite declines in incidence, gastric cancer remains a disease with a poor prognosis and limited treatment options due to its often late stage of diagnosis. In contrast, early gastric cancer has a good to excellent prognosis, with 5-year survival rates as high as 92.6% after endoscopic resection. There remains an East-West divide for this disease, with high incidence countries such as Japan seeing earlier diagnoses and reduced mortality, in part thanks to the success of a national screening programme. With missed cancers still prevalent at upper endoscopy in the West, and variable approaches to assessment of the high-risk stomach, the quality of endoscopy we provide must be a focus for improvement, with particular attention paid to the minority of patients at increased cancer risk. High-definition endoscopy with virtual chromoendoscopy is superior to white light endoscopy alone. These enhanced imaging modalities allow the experienced endoscopist to accurately and robustly detect high-risk lesions in the stomach. An endoscopy-led staging strategy would mean biopsies could be targeted to histologically confirm the endoscopic impression of premalignant lesions including atrophic gastritis, gastric intestinal metaplasia, dysplasia and early cancer. This approach to quality improvement will reduce missed diagnoses and, combined with the latest endoscopic resection techniques performed at expert centres, will improve early detection and ultimately patient outcomes. In this review, we outline the latest evidence relating to diagnosis, staging and treatment of early gastric cancer and its precursor lesions.